COVID-19 vaccine: Johnson & Johnson to begin vaccine trial soon


By MYBRANDBOOK


COVID-19 vaccine: Johnson & Johnson to begin vaccine trial soon

As the period of pandemic is rising day by day, drug makers are in full strength to work for  the COVID-19 antidote. Johnson & Johnson has stated that they would start human trials of its potential COVID-19 vaccine in the second half of July, two months earlier than planned.

 

The company has already signed deals with the US government to create enough manufacturing capacity to produce more than 1 billion doses of its vaccine through 2021.

 

J&J’s study will test the vaccine against a placebo and assess the shot’s safety and immune response in 1,045 healthy people aged 18 to 55 years, as well as those 65 years and older. The United States and Belgium will be trial schools.

 

US biotech Moderna Inc is at the forefront of COVID-19 vaccine development and has started testing its candidate in a mid-stage trial that will enroll 600 patients. The company expects to begin late-stage trials in July.

 

AstraZeneca, Sanofi, Pfizer and GlaxoSmithKline are all at various stages of development of their vaccine candidates.

 

There are currently about 10 coronavirus vaccines being tested in humans and experts have predicted that a safe and effective vaccine could take 12 to 18 months from the start of development.

 E-Magazine 
 VIDEOS  Placeholder image

Copyright www.mybrandbook.co.in @1999-2024 - All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission of Kalinga Digital Media Pvt. Ltd. is prohibited.
Other Initiatives : www.varindia.com | www.spoindia.org